CONTROVERSIES IN LUNG CANCER:A MULTIDISCIPLINARY APPROACH. This item is unavailable.CONTROVERSIES IN LUNG CANCER:A MULTIDISCIPLINARY APPROACH

Presenting contrasting viewpoints of leading national and international authorities, this illuminating reference explores unresolved issues in the treatment of patients with lung cancer. Providing evidence-based approaches to specific concerns in therapeutic management, Controversies in Lung Cancer guides clinicians confronting decisions regarding day-to-day oncologic practice.
Includes opposing opinions on, among other issues, the timing of thoracic radiotherapy for patients with limited stage small cell lung cancer, by Dr. Nevin Murray, British Columbia Cancer Agency, Vancouver, Canada, and Dr. Michael Perry, Ellis Fischel Cancer Center, Columbia, Missouri!
Emphasizing quality of life, nutrition, and supportive care of lung cancer patients, Controversies in Lung Cancer considers

dose intensification of chemotherapy in small cell and non-small cell lung cancer

the value of three-dimensional conformal radiotherapy

endobronchial brachytherapy

management of superior sulcus tumors

and more!
With over 1700 literature references, drawings, photographs, and tables, Controversies in Lung Cancer is a timely resource for medical, radiation, and thoracic oncologists; thoracic surgeons; pulmonologists; hematologists; primary care physicians; nurses; and medical school students and residents in these disciplines.

"From the Foreword For the clinician involved in the management of lung cancer, this book is an invaluable resource. Because of our increasing workloads, we have considerable difficulty in collecting and assimilating, on our own, the critical information necessary to provide the best possible care for patients. The well-organized and thoughtful presentations in Controversies in Lung Cancer will help the multidisciplinary team of lung cancer physicians and nurses to achieve their primary objectives"-to improve not only the quantity, but also the quality, of life for patients with lung cancer. -Philip Bonomi, M.D. Director, Section of Medical Oncology Rush-Presbyterian-St. Luke's Medical Center Chicago, Illinois